相关实验视频

Updated: Jun 6, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

多发性骨髓瘤中CAR-T细胞疗法:当前状况和未来的挑战

Dawn Swan¹, Deepu Madduri², Jay Hocking³

¹Department of Haematology, Austin Health, Melbourne, VIC, Australia. dawnswan123@gmail.com.

Blood cancer journal

|November 26, 2024

概括

对多发性骨髓瘤的化学抗原受体T细胞 (CAR-T) 疗法显示出有前途. 本综述探讨了通过解决抗原损失和毒性等挑战来提高CAR-T疗效,以改善患者的治疗结果.

科学领域:

血液学和瘤学研究
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

最近,多发性骨髓瘤治疗有了显著的进步.
针对B细胞成熟抗原 (BCMA) 的化学抗原受体T细胞 (CAR-T) 治疗已被批准用于复发/耐药患者.
在早期的治疗方案中,CAR-T疗法越来越多地被使用.

研究的目的:

审查支持当前针对BCMA的CAR-T治疗批准的证据.
探索提高多发性骨髓瘤中CAR-T细胞疗效的策略.
讨论优化CAR-T疗法的挑战和潜在解决方案.

主要方法:

审查当前的科学文献和临床试验数据.
对向BCMA的CAR-T疗法的作用机制和耐药性的分析.
讨论制造,安全和患者选择方面的考虑.

主要成果:

针对BCMA的CAR-T疗法代表了多发性骨髓瘤治疗的重大进展.
主要挑战包括BCMA损失,瘤微环境,制造复杂性和安全问题 (细胞因子释放综合征,神经毒性).
最佳的患者选择对于最大化治疗效益至关重要.

结论:

卡特-T疗法为多发性髓瘤提供了一种强大的新疗法.
解决已确定的挑战对于改善和扩大CAR-T细胞疗法的有效性至关重要.
对优化CAR-T细胞设计,制造和患者管理的进一步研究是有必要的.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...